about
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDAmphetamine, past and present--a pharmacological and clinical perspectiveUpdate on optimal use of lisdexamfetamine in the treatment of ADHD.New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children.Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lisdexamfetamine dimesylate for childhood ADHD.
@en
Lisdexamfetamine dimesylate for childhood ADHD.
@nl
type
label
Lisdexamfetamine dimesylate for childhood ADHD.
@en
Lisdexamfetamine dimesylate for childhood ADHD.
@nl
prefLabel
Lisdexamfetamine dimesylate for childhood ADHD.
@en
Lisdexamfetamine dimesylate for childhood ADHD.
@nl
P1433
P1476
Lisdexamfetamine dimesylate for childhood ADHD.
@en
P2093
Vishal Madaan
P304
P356
10.1358/DOT.2008.44.5.1215724
P577
2008-05-01T00:00:00Z